Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (91-100 of 326) with videos related to

Pageof 33
Sort By:
Frontiers in Medicine|January 4, 2021
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver DiseaseKonstantin Kazankov, Chiara Rosso, Ramy Younes, et al.
International Journal of Molecular Sciences|December 16, 2016
Pathophysiology of Non Alcoholic Fatty Liver DiseaseSalvatore Petta, Amalia Gastaldelli, Eleni Rebelos, et al.
Antibiotics (Basel, Switzerland)|March 27, 2024
<i>Helicobacter pylori</i> in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?Elisabetta Bretto, Simone Frara, Angelo Armandi, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and deathAlexander Lynge Reese-Petersen, Signe Holm Nielsen, Jannie Marie Bülow Sand, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverElisabetta Bugianesi, Paola Manzini, Sergio D'Antico, et al.
Journal of Clinical Medicine|December 9, 2020
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational StudyMarta Vernero, Federico De Blasio, Davide Giuseppe Ribaldone, et al.
Nutrients|July 29, 2023
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Chiara Rosso, et al.
Journal of Hepatology|December 4, 2012
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver diseaseElena Centis, Simona Moscatiello, Elisabetta Bugianesi, et al.
Obesity (Silver Spring, Md.)|October 23, 2010
Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational studySimona Moscatiello, Raffaella Di Luzio, Elisabetta Bugianesi, et al.
Minerva Gastroenterology|March 9, 2023
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver diseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Marta Guariglia, et al.
Pageof 33

Showing results (91-100 of 326) with videos related to

Sort By:
Pageof 33
Frontiers in Medicine|January 4, 2021
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver DiseaseKonstantin Kazankov, Chiara Rosso, Ramy Younes, et al.
International Journal of Molecular Sciences|December 16, 2016
Pathophysiology of Non Alcoholic Fatty Liver DiseaseSalvatore Petta, Amalia Gastaldelli, Eleni Rebelos, et al.
Antibiotics (Basel, Switzerland)|March 27, 2024
<i>Helicobacter pylori</i> in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?Elisabetta Bretto, Simone Frara, Angelo Armandi, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and deathAlexander Lynge Reese-Petersen, Signe Holm Nielsen, Jannie Marie Bülow Sand, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverElisabetta Bugianesi, Paola Manzini, Sergio D'Antico, et al.
Journal of Clinical Medicine|December 9, 2020
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational StudyMarta Vernero, Federico De Blasio, Davide Giuseppe Ribaldone, et al.
Nutrients|July 29, 2023
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Chiara Rosso, et al.
Journal of Hepatology|December 4, 2012
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver diseaseElena Centis, Simona Moscatiello, Elisabetta Bugianesi, et al.
Obesity (Silver Spring, Md.)|October 23, 2010
Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational studySimona Moscatiello, Raffaella Di Luzio, Elisabetta Bugianesi, et al.
Minerva Gastroenterology|March 9, 2023
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver diseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Marta Guariglia, et al.
Pageof 33